Corient Private Wealth LLC Acquires 67,149 Shares of Mettler-Toledo International, Inc. $MTD

Corient Private Wealth LLC lifted its holdings in Mettler-Toledo International, Inc. (NYSE:MTD) by 91.8% in the 2nd quarter, Holdings Channel.com reports. The firm owned 140,267 shares of the medical instruments supplier’s stock after acquiring an additional 67,149 shares during the quarter. Corient Private Wealth LLC’s holdings in Mettler-Toledo International were worth $164,775,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Sound Income Strategies LLC lifted its holdings in Mettler-Toledo International by 477.8% during the second quarter. Sound Income Strategies LLC now owns 52 shares of the medical instruments supplier’s stock worth $61,000 after buying an additional 43 shares during the period. Acadian Asset Management LLC raised its position in shares of Mettler-Toledo International by 84.9% in the 1st quarter. Acadian Asset Management LLC now owns 2,513 shares of the medical instruments supplier’s stock worth $2,965,000 after acquiring an additional 1,154 shares in the last quarter. Financial Advisors Network Inc. boosted its position in Mettler-Toledo International by 808.9% during the first quarter. Financial Advisors Network Inc. now owns 3,254 shares of the medical instruments supplier’s stock valued at $3,843,000 after purchasing an additional 2,896 shares in the last quarter. Focus Partners Wealth grew its stake in Mettler-Toledo International by 85.6% in the first quarter. Focus Partners Wealth now owns 3,195 shares of the medical instruments supplier’s stock valued at $3,774,000 after purchasing an additional 1,474 shares during the last quarter. Finally, CW Advisors LLC raised its holdings in Mettler-Toledo International by 250.3% in the first quarter. CW Advisors LLC now owns 620 shares of the medical instruments supplier’s stock worth $737,000 after purchasing an additional 443 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Trading Down 1.9%

Shares of NYSE:MTD opened at $1,394.97 on Monday. Mettler-Toledo International, Inc. has a twelve month low of $946.69 and a twelve month high of $1,525.17. The company has a market cap of $28.50 billion, a PE ratio of 34.79, a price-to-earnings-growth ratio of 4.50 and a beta of 1.40. The company’s 50 day moving average is $1,402.13 and its 200 day moving average is $1,293.95.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm earned $10.21 EPS. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the stock. Bank of America lifted their price objective on shares of Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the stock a “neutral” rating in a research report on Monday, September 22nd. Citigroup lifted their price target on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the stock a “buy” rating in a report on Monday, November 10th. Barclays increased their price objective on Mettler-Toledo International from $1,350.00 to $1,600.00 and gave the company an “overweight” rating in a report on Monday, November 10th. JPMorgan Chase & Co. boosted their target price on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Finally, The Goldman Sachs Group initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price objective on the stock. Five analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $1,424.17.

Insiders Place Their Bets

In other Mettler-Toledo International news, Director Elisha W. Finney sold 474 shares of Mettler-Toledo International stock in a transaction on Monday, November 10th. The shares were sold at an average price of $1,433.57, for a total value of $679,512.18. Following the completion of the transaction, the director owned 311 shares of the company’s stock, valued at approximately $445,840.27. The trade was a 60.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Shawn Vadala sold 1,895 shares of the stock in a transaction dated Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer directly owned 5,288 shares in the company, valued at approximately $7,696,789.76. The trade was a 26.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 19,565 shares of company stock worth $28,683,737. 0.77% of the stock is currently owned by company insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.